Broadwater Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50
Closed -$38.8K 227
2024
Q4
$38.8K Hold
50
0.03% 117
2024
Q3
$44.5K Hold
50
0.03% 121
2024
Q2
$45.4K Hold
50
0.04% 122
2024
Q1
$39K Hold
50
0.03% 125
2023
Q4
$29.1K Buy
+50
New +$29.2K 0.02% 133

Other funds holding LLY

Broadwater Capital's LLY Position: Q1 2025 in Review

Broadwater Capital sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 50 shares — an estimated $38.8K sold.

Broadwater Capital first reported a position in LLY in Q4 2023 and held it in 5 quarters. The position peaked at $45.4K in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Broadwater Capital reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Broadwater Capital sold 50 Eli Lilly shares in Q1 2025, an estimated $38.8K.
  • Broadwater Capital first reported a position in Eli Lilly in Q4 2023 and held it in 5 quarters.
  • Broadwater Capital's Eli Lilly position peaked at $45.4K in Q2 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Broadwater Capital's 13F filing for Q1 2025, filed 31 Oct 2025.